The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript Revenue surged 99% year-over-year on HEMANGEOL relaunch and rare disease portfolio growth.
Grandstand (GRSD) Q2 2026 Earnings Call Transcript B2B sports data surged 12% as restructuring unlocked $13M in annual savings.
Oxbridge Re (OXBR) Q2 2026 Earnings Call Transcript Reinsurance tokenization platform SurancePlus raised over $16 million since launch.
Cineverse (CNVS) Q1 2027 Earnings Call Transcript Revenue surged 175% as technology services now drive over 60% of total income.
PetMed Express (PETS) Q1 2027 Earnings Call Transcript Management evaluates $3-per-share offer while pursuing partnerships and operational improvements.
NextNRG (NXXT) Q2 2026 Earnings Call Transcript Net loss fell 81.7% as mobile fueling revenue surged 40.9%.
ImmuCell (ICCC) Q2 2026 Earnings Call Transcript Product sales hit $7.2 million as market share climbed to 19% amid capacity expansion plans.
Sensus (SRTS) Q2 2026 Earnings Call Transcript Financing delays crushed Q2 revenue, but management expects recovery in Q3.
Intellicheck (IDN) Q2 2026 Earnings Call Transcript Revenue grew 16% year-over-year despite major customer transition risks.
Cibus (CBUS) Q2 2026 Earnings Call Transcript Gene-editing biotech targets $200M+ rice royalty opportunity with cash runway into 2027.
Faraday Future (FFAI) Q2 2026 Earnings Call Transcript Revenue surged 1,400% while net losses narrowed 69% as robotics scaling accelerates.
Capricor (CAPR) Q2 2026 Earnings Call Transcript Deramiocel faces regulatory headwinds; management pursues upper limb indication.
TSS (TSSI) Q2 2026 Earnings Call Transcript Gross margins expanded 640 basis points as AI infrastructure demand surged.
Innventure (INV) Q2 2026 Earnings Call Transcript Accelsius hits infrastructure headwinds as early adopters face power and GPU constraints.
AirJoule (AIRJ) Q2 2026 Earnings Call Transcript Water scarcity is opening commercial doors for atmospheric harvesting technology.
Is Palantir Still a Buy After Its 33% Rally Over the Past Month? This recent rally brought Palantir back into the green compared to a year ago. Is now a good time to buy the stock?
Stock Market Today, Aug. 20: Stocks Slide on Weak Retail Earnings, Rising Bond Yields Today, Aug. 20, 2026, disappointing consumer results and rising oil prices snapped Wednesday's relief rally, renewing inflation concerns across major indexes.
Why Hecla Mining Stock Is Soaring This Week This precious metals stock looks much more lustrous for one obvious reason.
Genasys (GNSS) Q3 2026 Earnings Call Transcript Software revenue jumped 21% year over year as gross margins expanded to 57.1%.
Health In Tech (HIT) Q2 2026 Earnings Call Transcript CEO Johnson projects A-rated carrier status could boost financials 20% to 30%.
Quantum-Si (QSI) Q2 2026 Earnings Call Transcript Proteus launch delayed to Q2 2027 as company cuts costs and eyes $4B market opportunity.
KinderCare (KLC) Q2 2026 Earnings Call Transcript Center closures weigh on earnings as enrollment pressures offset Champions growth.
Jefferson Capital (JCAP) Q2 2026 Earnings Call Transcript Collections surged 18% as company enters Mexico and expands into auto finance.
Newsmax (NMAX) Q2 2026 Earnings Call Transcript First profitable quarter as affiliate fees and licensing surge.
Kyntra Bio (KYNB) Q2 2026 Earnings Call Transcript FG-3246 Phase II trial advances with 36% PSA50 response in monotherapy.
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.
York Space Systems (YSS) Q2 2026 Earnings Call Transcript Revenue guidance cut by $180 million as supply chain delays push contracts into 2027.
Globant (GLOB) Q2 2026 Earnings Call Transcript Glob.AI ARR jumped 61% to $52.8M as AI-native delivery accelerates.
GE Vernova's AI Data Center Orders Just Doubled All of 2025 in 1 Half-Year. Is the Stock Still a Buy? The stock's fully reflecting the company's recent revenue growth, led by demand from the artificial intelligence industry.
Stock Market Today, Aug. 20: Walmart Stock Drops on Disappointing Comparable Sales Growth Walmart's U.S. sales and traffic missed Wall Street expectations, pressuring shares despite a raised full-year outlook, today, Aug. 20, 2026.
A Ziff Davis Director Sells 2,513 Shares as the Stock Soars. Here's a Closer Look at the Transaction. The digital media company reported a notable insider disposition following a 49% one-year rally in share price.
Stock Market Today, Aug. 20: Webull Initially Surges 14%, Ends 2% Higher After Record Q2 Revenue and Earnings Beat On Aug. 20, 2026, the digital brokerage posted $198.8 million in revenue with trading-related income up 66% year over year, fueling investor optimism.
Xos (XOS) Q2 2026 Earnings Call Transcript Orders shifted to later quarters, but gross margins hit record highs.
HawkEye 360 (HAWK) Q2 2026 Earnings Call Transcript Revenue surged 87% year-over-year to $49.8 million, while international sales hit record highs.
Digimarc (DMRC) Q2 2026 Earnings Call Transcript Contract losses offset margin gains and accelerating gift card momentum.
KULR (KULR) Q2 2026 Earnings Call Transcript Supply chain bottlenecks crushed revenue, but defense drone orders signal recovery.
DLocal (DLO) Q2 2026 Earnings Call Transcript TPV surged 92% as ride-hailing and travel merchants drove growth across Latin America.
Celcuity (CELC) Q2 2026 Earnings Call Transcript Revtopik launch underway with 80 oncology specialists supporting expansion into first-line treatment.
Aya Gold & Silver (AYA) Q2 2026 Earnings Call Transcript Silver production surged 61% year over year as Zgounder ramp-up accelerated.
Swarmer (SWMR) Q2 2026 Earnings Call Transcript SkyKnight licensing expanded to $3.9M as combat deployments fuel AI model refinement.
XLF vs EUFN: Is a U.S. Financials ETF Superior to a Europe-Focused Fund? State Street's fund tracks JPMorgan and Berkshire, while iShares targets HSBC and Santander. One prioritizes affordability; the other, income.
Applied Materials (AMAT) Q3 2026 Earnings Call Transcript AI infrastructure demand drove $9.12B revenue and record profitability.
ARS Pharma (SPRY) Q2 2026 Earnings Call Transcript Neffy market share doubled as prescriber count tripled year over year.
Prediction: Cybercab Adds Less Than 5% to Tesla's Revenue in Its First Full Year Tesla built the line, and Tesla published its capacity. Even a first year running at that capacity barely moves a $95 billion revenue base.
Smith Micro (SMSI) Q2 2026 Earnings Call Transcript Sequential revenue growth returns for second consecutive quarter as margins improve.
Elutia (ELUT) Q2 2026 Earnings Call Transcript CEO Mills reports 96% surgeon interest in NXT-41x platform ahead of late 2026 FDA clearance.
Daré Bioscience (DARE) Q2 2026 Earnings Call Transcript Net loss narrowed to $3 million as nondilutive funding offset R&D costs.
Texas Roadhouse Director Sells 869 Shares for $180,000 -- Should Investors Beware? Donna Epps reduced her equity stake by 18% through a combination of open market sales and gifted shares, while maintaining a direct position of nearly 4,000 shares.
Why Estee Lauder Rallied This Week Management gave a positive update on the company's multi-year turnaround efforts.
Vanguard VCIT vs Fidelity FIGB: Which Bond ETF Is the Better Choice for Investors in 2026? VCIT charges just 0.03% annually and holds $69.5 billion in assets, while FIGB offers a more conservative risk profile with lower volatility.
Automatic Data Processing vs. Microsoft: Which Technology Stock Is a Better Buy in 2026? ADP's 20% net margin and $5.2B free cash flow contrast sharply with Microsoft's 40% margin and $67B cash generation, revealing starkly different paths to shareholder value.
